drugset / Trial / NCT02941315

Risk Stratification of Heart Failure in Cardiomyopathies.

NCT02941315

Phase 1 Completed 150 enrolled RenJi Hospital Ruijin Hospital · collab
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The investigators aimed to use CMR technique in helping diagnose the etiology of unknown cardiomyopathy. Try to make a risk stratification of susceptible heart failure based on the extent of myocardial impairment.

Timeline

Start
2016-12-01
Primary completion
2021-10-01
Completion
2022-11-01

Drugs

EvaluationDrugModalityDoseRoute
Background Captopril Small molecule
Comparator Spironolactone Small molecule
Comparator fursemide Unknown